Life Science Leader Magazine Supplements

CRO Leadership Awards 2013

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/111709

Contents of this Issue

Navigation

Page 29 of 45

Product Safety Labs ��� Dayton, NJ www.productsafetylabs.com ��� (732) 438-5100 contact: Gary Wnorowski ��� Garywnorowski@productsafetylabs.com Drug Life Cycle Stages: Research & Development ��� Discovery, Preclinical Main Service Areas: Preclinical SERVICES & CAPABILITIES: Contract research organization providing GLP toxicology and analytical services. KEY INDUSTRY PARTNERS: Several years ago, PSL established a strategic partnership with Eurofins��� global laboratory network which has significantly enhanced the diversity of services we offer our clients. ���For over 35 years Product Safety Labs (PSL) has been a CRO industry leader, providing toxicology and analytical chemistry services for global regulatory product registration. We are pleased that our clients have recognized our achievements in the areas of regulatory excellence, quality, and reliability. PSL remains committed to offering outstanding quality, competitive prices, and an ever-expanding scope of services.��� ��� Gary Wnorowski, president Quanticate ��� Boston, MA ��� www.quanticate.com ��� (617) 973-5119 key locations: Bangalore, India; Bloemfontein, South Africa; Boston, MA; Canterbury, UK; Hitchin, Hertfordshire, UK (HQ); Manchester, UK; Oxford, UK; and Warsaw, Poland contact: Thomas Underwood ��� Thomas.underwood@quanticate.com Drug Life Cycle Stages: Research & Development ��� Clinical (Phase 1, Phase 2, and Phase 3) Main Service Areas: Bioanalytical, Clinical SERVICES & CAPABILITIES: Quanticate, one of the world���s leading data-focused CROs, specializes in the provision of biostatistics, programming, clinical data management, medical writing, and pharmacovigilance services. THERAPEUTIC AREAS: Allergy, cardiovascular/metabolic, CNS, dermatology, endocrinology, gastroenterology, hematology, anti-infectivies, infectious diseases, musculoskeletal, rheumatology & osteology, nephrology, renal, & urology, neurosciences, nutrition, obstetrics/gynecology, oncology, ophthalmology, pain management, rare diseases, respiratory and immuno-inflammatory, transplantation, vaccine & virology KEY INDUSTRY PARTNERS: Clinical Ink and Comprehend Clinical ���Quanticate is honored to be recognized as a top tier organization and industry leader in the area of Innovation. Our company is focused on offering the best possible solutions now and looking at what our customers will need in the future. We believe that the development of technologies such as our innovative study management and data visualizion portal, CliQ is part of the reason that customers have recognized us for this award.��� ��� David Underwood, president and CEO Quintiles ��� Durham, NC www.Quintiles.com ��� (866) 267-4479 key locations: United Kingdom and United States Drug Life Cycle Stages: Research & Development ��� Clinical (Phase 1, Phase 2, and Phase 3) Main Service Areas: Bioanalytical, Clinical SERVICES & CAPABILITIES: Quintiles is the world���s leading provider of biopharmaceutical services. With more than 27,000 professionals in 80+ countries, we helped develop or commercialize all of the top 50 best selling drugs. THERAPEUTIC AREAS: Cardiovascular, central nervous system, diabetes & endocrinology, immunology, infectious diseases, internal medicine, oncology, translational oncology, pediatrics, public health, and vaccines KEY INDUSTRY PARTNERS: BioCore for Bioanalytical Services; Samsung biopharma (2011); Nycomed; Takeda-Japan, AZ-Clinical pharmacology ���We are honored to receive a CRO leadership award for innovation, productivity, and regulatory. Our selection is recognition of Quintiles��� success in strengthening and transforming our clinical development business to meet and exceed customer needs. We are effective when we anticipate where the market is going so we can guide our customers and remain the clear leader in product development services in the New Health.��� ��� Paula Brown Stafford, president, cinical development 28 The CRO Leadership Awards 2013

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2013